期刊文献+

观察益元清肝健运汤治疗2型糖尿病合并高脂血症的临床疗效 被引量:6

Clinical efficacy of the Yiyuan Qinggan Jianyun decoction on type 2 diabetes with hyperlipidemia
下载PDF
导出
摘要 目的:研究讨论2型糖尿病合并高脂血症患者应用益元清肝健运汤治疗的临床效果。方法:本实验共选取2型糖尿病合并高脂血症患者65例,按照随机数字表法将其分成两组,研究组的33例患者应用益元清肝健运汤治疗,对照组32例患者行西医综合方案治疗即可。结果:相比于对照组,研究组患者血糖和血脂水平中总胆固醇、低密度脂蛋白胆固醇和甘油三酯指标数据更低;而研究组患者高密度脂蛋白胆固醇指标数据更高(P<0.05),该组患者临床效果更好、症状改善更明显。结论:2型糖尿病合并高血脂患者在临床治疗中应用益元清肝健运汤治疗,临床效果更好,用药后能够有效改善患者血糖、血脂水平情况,控制病情发展,应用价值明显。 Objective:To evaluate clinical effects of the Yiyuan Qinggan Jianyun decoction(益元清肝健运汤)on type 2 diabetes with hyperlipidemia.Methods:65 cases were selected and divided into two groups according to the random digital table.33 patients in the study group were treated with the Yiyuan Qinggan Jianyun decoction and 32 patients in the control group took western medicine comprehensive treatment.Results:The total cholesterol,LDL cholesterol and triglyceride in blood glucose and blood lipid of the patients in the study group were lower than those in the control group,while HDL cholesterol index in the study group was higher(P<0.05).The clinical effects in the study group was better,and the symptom was improved obviously.Conclusion:The Yiyuan Qinggan Jianyun decoction gained better clinical effects.The patients’blood glucose and blood lipid level could be effectively improved,and the disease could be controlled.The application value is obvious.
作者 邓怀道
出处 《中医临床研究》 2018年第5期54-55,共2页 Clinical Journal Of Chinese Medicine
关键词 2型糖尿病 高血脂症 益元清肝健运汤 临床疗效 Type 2 diabetes Hyperlipidemia The Yiyuan Qinggan Juanyun decoction Clinical efficacy
  • 相关文献

参考文献7

二级参考文献59

  • 1中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5228
  • 2郑筱萸.中药新药临床研究指导原则[M]第1版[M].北京:中国医药科技出版社,2002.69-73.
  • 3D'Ominguec JH,Tang N,Xu W ,et al. Studies of renal injury Ⅲ : lipid induced nephropathy In type Ⅱ diabetes [J]. Kidney Int, 2000,57 : 92-99.
  • 4Levin K, Schroeder HD, Alford FP, et al. Morpho- metric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes[J] . Diabetologia, 2001,44 (7) : 824- 833.
  • 5Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease -The common soil hypothesis re- visited[J]. Arteriosclerosis , 2004,11 (1) : 1-11.
  • 6MeGarry JD. Banting lecture2001 : dysregulation of fatty acid metabolism in the etiology of type2 diabetes[J]. Diabetes,2002,75(12) : 3972-3979.
  • 7Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection. Evaluation and treatment of high blood cholesterol in adults(adult treatment panel Ⅲ )[J]. The Journal of the American Medical Association, 2011,83 (1) : 9-18.
  • 8Bajaj M, Berria R, Pratipanawatr T, et el. Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans[J]. A- merican Journal of Physiology Endocrinology and Me- tabolism,2002,7(4) : 1-12.
  • 9Mukamal KJ, Nesto RW, Cohen MC, et al. Impact of diabetes on long-term survival after acute myocardial in- farction: comparability of risk with prior myocardial in- farction[J]. Diabetes Care , 2001,40(2) : 720-729.
  • 10Kabadi MU, Kabadi UM. Effects of glimepiride on in- sulin secretion and sensitivity in pations with recently diagnosed type2diabetes mellitus[J]. Clinical Therapeu- tics ,2004,81(1): 1-7.

共引文献84

同被引文献101

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部